Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

NCT07031674 is registered in ClinicalTrials.gov with Yipeng Liu as lead sponsor.

NCT NCT07031674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07031674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.
Lead sponsor
Yipeng Liu
Phase
Observational
Overall status
Completed
Start date
October 1, 2025
Completion date
December 31, 2025
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

belimumab, lupus nephritis